Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia

Journal of Agricultural and Food Chemistry

Volumn 59, Issue 9, 2011, Pages 4553-4561

  Hsu, Chin ^a   Hsieh, Chin Lin ^b   Kuo, Yueh Hsiung ^a,c,d   Huang, Ching Jang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Taiwan Police College   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

Author keywords

Cucurbitane type triterpenoid; Estrogen receptor; Momordica charantia; Partial agonist antagonist; Transactivation assay

Indexed keywords

ESTROGEN RECEPTOR; MOMORDICA CHARANTIA; PARTIAL AGONIST/ANTAGONIST; TRANSACTIVATION; TRITERPENOIDS;

ESTERS; ETHANOL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OLEFINS;

COLUMN CHROMATOGRAPHY;

ESTROGEN RECEPTOR; PLANT EXTRACT; TRITERPENE;

ARTICLE; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOMORDICA CHARANTIA; TRANSCRIPTION INITIATION;

CELL LINE; GENE EXPRESSION; HUMANS; MOMORDICA CHARANTIA; PLANT EXTRACTS; RECEPTORS, ESTROGEN; TRANSCRIPTIONAL ACTIVATION; TRITERPENES;

CUCURBITA; MOMORDICA CHARANTIA;

EID: 79955679532     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf200418g     Document Type: Article

References (42)

1. Grover, J. K.; Yadav, S. P. Pharmacological actions and potential uses of Momordica charantia: a review. J. Ethnopharmacol. 2004, 93, 123-32. (Pubitemid 38739282)
2. Nerurkar, P.; Ray, R. B. Bitter melon: antagonist to cancer. Pharm. Res. 2010, 27, 1049-53.
3. Hasani-Ranjbar, S.; Nayebi, N.; Larijani, B.; Abdollahi, M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J. Gastroenterol. 2009, 15, 3073-85.
4. Yin, J.; Zhang, H.; Ye, J. Traditional chinese medicine in treatment of metabolic syndrome. Endocr. Metab. Immune Disord. Drug Targets 2008, 8, 99-111.
5. Basch, E.; Gabardi, S.; Ulbricht, C. Bitter melon (Momordica charantia): a review of efficacy and safety. Am. J. Health. Syst. Pharm. 2003, 60, 356-9. (Pubitemid 36749034)
6. Stepka, W.; Wilson, K. E.; Madge, G. E. Antifertility investigation on Momordica. Lloydia 1974, 37, 645.
7. Naseem, M. Z.; Patil, S. R.; Patil, S. R.; Ravindra; Patil, S. B. Antispermatogenic and androgenic activities of Momordica charantia (Karela) in albino rats. J. Ethnopharmacol. 1998, 61, 9-16. (Pubitemid 28276719)
8. McDonnell, D. P.; Connor, C. E.; Wijayaratne, A.; Chang, C.-y.; Norris, J. D. Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog. Horm. Res. 2002, 57, 295-316.
9. Oseni, T.; Patel, R.; Pyle, J.; Jordan, V. C. Selective estrogen receptor modulators and phytoestrogens. Planta Med. 2008, 74, 1656-65.
10. Love, R. R.; Mazess, R. B.; Barden, H. S.; Epstein, S.; Newcomb, P. A.; Jordan, V. C.; Carbone, P. P.; DeMets, D. L. Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer. N. Engl. J. Med. 1992, 326, 852-6.
11. Cummings, S. R.; Eckert, S.; Krueger, K. A.; Grady, D.; Powles, T. J.; Cauley, J. A.; Norton, L.; Nickelsen, T.; Bjarnason, N. H.; Morrow, M.; Lippman, M. E.; Black, D.; Glusman, J. E.; Costa, A.; Jordan, V. C. The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women. JAMA, J. Am. Med. Assoc. 1999, 281, 2189-97.
12. Ososki, A. L.; Kennelly, E. J. Phytoestrogens: a review of the present state of research. Phytother. Res. 2003, 17, 845-69. (Pubitemid 37157993)
13. Chao, C. Y.; Huang, C. J. Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells. J. Biomed. Sci. 2003, 10, 782-91.
14. Chuang, C. Y.; Hsu, C.; Chao, C. Y.; Wein, Y. S.; Kuo, Y. H.; Huang, C. J. Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.). J. Biomed. Sci. 2006, 13, 763-72. (Pubitemid 44900649)
15. Murakami, T.; Emoto, A.; Matsuda, H.; Yoshikawa, M. Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleananetype triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chem. Pharm. Bull. (Tokyo) 2001, 49, 54-63. (Pubitemid 32128095)
16. Chen, J. C.; Chiu, M. H.; Nie, R. L.; Cordell, G. A.; Qiu, S. X. Cucurbitacins and cucurbitane glycosides: structures and biological activities. Nat. Prod. Rep. 2005, 22, 386-99.
17. Cheng, W. Y.; Kuo, Y. H.; Huang, C. J. Isolation and identification of novel estrogenic compounds in yam tuber (Dioscorea alata Cv. Tainung No. 2). J. Agric. Food Chem. 2007, 55, 7350-8.
18. Durocher, Y.; Perret, S.; Thibaudeau, E.; Gaumond, M.-H.; Kamen, A.; Stocco, R.; Abramovitz, M. A Reporter Gene Assay for High-Throughput Screening of G-Protein-Coupled Receptors Stably or Transiently Expressed in HEK293 EBNA Cells Grown in Suspension Culture. Anal. Biochem. 2000, 284, 316-26.
19. Matsuda, H.; Nakamura, S.; Murakami, T.; Yoshikawa, M. Structure of New Cucurbitane-Type Triterpenes and Glycosides, Karavilagenins D and E, and Karavilosides VI, VII, VIII, IX, X, and IX, from the Fruit of Momordica charantia. Heterocycles 2007, 71, 331-41.
20. Li, Q. Y.; Chen, H. B.; Liu, Z. M.; Wang, B.; Zhao, Y. Y. Cucurbitane triterpenoids from Momordica charantia. Magn. Reson. Chem. 2007, 45, 451-6.
21. Mulholland, D. A.; Sewram, V.; Osborne, R.; Pegel, K. H.; Connolly, J. D. Cucurbitane triterpenoids from the leaves of Momordica foetida. Phytochemistry 1997, 45, 391-5. (Pubitemid 27180913)
22. Chang, C. I.; Chen, C. R.; Liao, Y. W.; Cheng, H. L.; Chen, Y. C.; Chou, C. H. Cucurbitane-type triterpenoids from the stems of Momordica charantia. J. Nat. Prod. 2008, 71, 1327-30.
23. Chen, C. R.; Liao, Y. W.; Wang, L.; Kuo, Y. H.; Liu, H. J.; Shih, W. L.; Cheng, H. L.; Chang, C. I. Cucurbitane triterpenoids from Momordica charantia and their cytoprotective activity in tert-butyl hydroperoxide-induced hepatotoxicity of HepG2 cells. Chem. Pharm. Bull. (Tokyo) 2010, 58, 1639-42.
24. Akihisa, T.; Higo, N.; Tokuda, H.; Ukiya, M.; Akazawa, H.; Tochigi, Y.; Kimura, Y.; Suzuki, T.; Nishino, H. Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects. J. Nat. Prod. 2007, 70, 1233-9. (Pubitemid 47401558)
25. Chang, C. I.; Chen, C. R.; Liao, Y. W.; Shih, W. L.; Cheng, H. L.; Tzeng, C. Y.; Li, J. W.; Kung, M. T. Octanorcucurbitane triterpenoids protect against tert-butyl hydroperoxide-induced hepatotoxicity from the stems of Momordica charantia. Chem. Pharm. Bull. (Tokyo) 2010, 58, 225-9.
26. Chen, J. C.; Liu, W. Q.; Lu, L.; Qiu, M. H.; Zheng, Y. T.; Yang, L. M.; Zhang, X. M.; Zhou, L.; Li, Z. R.; Kuguacins, F-S cucurbitane triterpenoids from Momordica charantia. Phytochemistry 2009, 70, 133-40.
27. Tan, M. J.; Ye, J. M.; Turner, N.; Hohnen-Behrens, C.; Ke, C. Q.; Tang, C. P.; Chen, T.; Weiss, H. C.; Gesing, E. R.; Rowland, A.; James, D. E.; Ye, Y. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem. Biol. 2008, 15, 263-73. (Pubitemid 351381992)
28. Ukiya, M.; Akihisa, T.; Tokuda, H.; Toriumi, M.; Mukainaka, T.; Banno, N.; Kimura, Y.; Hasegawa, J.; Nishino, H. Inhibitory effects of cucurbitane glycosides and other triterpenoids fromthe fruit of Momordica grosvenori on epstein-barr virus early antigen induced by tumor promoter 12-O- tetradecanoylphorbol-13-acetate. J. Agric. Food Chem. 2002, 50, 6710-5. (Pubitemid 35253162)
29. Clericuzio, M.; Mella, M.; Vita-Finzi, P.; Zema, M.; Vidari, G. Cucurbitane triterpenoids from Leucopaxillus gentianeus. J. Nat. Prod. 2004, 67, 1823-8. (Pubitemid 39602358)
30. Zhang, J.; Guo, H.; Tian, Y.; Liu, P.; Li, N.; Zhou, J.; Guo, D. Biotransformation of 20(S)-protopanaxatriol by Mucor spinosus and the cytotoxic structure activity relationships of the transformed products. Phytochemistry 2007, 68, 2523-30. (Pubitemid 47451448)
31. Harinantenaina, L.; Tanaka, M.; Takaoka, S.; Oda, M.; Mogami, O.; Uchida, M.; Asakawa, Y. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem. Pharm. Bull. (Tokyo) 2006, 54, 1017-21.
32. Ramalhete, C.; Mansoor, T. A.; Mulhovo, S.; Molnar, J.; Ferreira, M. J. Cucurbitane-type triterpenoids from the African plant Momordica balsamina. J. Nat. Prod. 2009, 72, 2009-13.
33. DuSell, C. D.; Umetani, M.; Shaul, P. W.; Mangelsdorf, D. J.; McDonnell, D. P. 27-Hydroxycholesterol Is an Endogenous Selective Estrogen Receptor Modulator. Mol. Endocrinol. 2008, 22, 65-77.
34. Umetani, M.; Domoto, H.; Gormley, A. K.; Yuhanna, I. S.; Cummins, C. L.; Javitt, N. B.; Korach, K. S.; Shaul, P. W.; Mangelsdorf, D. J. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat. Med. 2007, 13, 1185-92. (Pubitemid 47530633)
35. Ju, Y. H.; Clausen, L. M.; Allred, K. F.; Almada, A. L.; Helferich, W. G. beta-Sitosterol, beta-Sitosterol Glucoside, and a Mixture of beta- Sitosterol and beta-Sitosterol Glucoside Modulate the Growth of Estrogen-Responsive Breast Cancer Cells In Vitro and in Ovariectomized Athymic Mice. J. Nutr. 2004, 134, 1145-51. (Pubitemid 38619954)
36. Newill, H.; Loske, R.; Wagner, J.; Johannes, C.; Lorenz, R. L.; Lehmann, L. Oxidation products of stigmasterol interfere with the action of the female sex hormone 17beta-estradiol in cultured human breast and endometrium cell lines. Mol. Nutr. Food Res. 2007, 51, 888-98. (Pubitemid 47173699)
37. Yamamoto, Y.; Shibata, J.; Yonekura, K.; Sato, K.; Hashimoto, A.; Aoyagi, Y.; Wierzba, K.; Yano, S.; Asao, T.; Buzdar, A. U.; Terada, T. TAS- 108, a Novel Oral Steroidal Antiestrogenic Agent, Is a Pure Antagonist on Estrogen ReceptorR and a Partial Agonist on Estrogen Receptor β with Low Uterotrophic Effect. Clin. Cancer Res. 2005, 11, 315-22. (Pubitemid 40075810)
38. von Angerer, E.; Biberger, C.; Holler, E.; Koop, R.; Leichti, S. 1-carbamoylalkyl-2-phenylindoles: Relationship between side chain structure and estrrogen antagonism. J. Steroid Biochem. Mol. Biol. 1994, 49, 51-62. (Pubitemid 24219209)
39. Dayan, G.; Lupien, M.; Auger, A.; Anghel, S. I.; Rocha, W.; Croisetiére, S.;Katzenellenbogen, J.A.;Mader, S. Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor R. Mol. Pharmacol. 2006, 70, 579-88. (Pubitemid 44092319)
40. Roelens, F.;Heldring, N.; Dhooge,W.; Bengtsson,M.; Comhaire, F.; Gustafsson, J.-Å.; Treuter, E.; De Keukeleire, D. Subtle Side-Chain Modifications of the Hop Phytoestrogen 8-Prenylnaringenin Result in Distinct Agonist/Antagonist Activity Profiles for Estrogen Receptors R and β. J. Med. Chem. 2006, 49, 7357-65. (Pubitemid 44920186)
41. Nettles, K. W.; Sun, J.; Radek, J. T.; Sheng, S.; Rodriguez, A. L.; Katzenellenbogen, J. A.; Katzenellenbogen, B. S.; Greene, G. L. Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors. Mol. Cell 2004, 13, 317-27. (Pubitemid 38229805)
42. Hong, Y. H.;Wang, S. C.; Hsu, C.; Lin, B. F.; Kuo, Y. H.; Huang, C. J. Phytoestrogenic Compounds in Alfalfa Sprout (Medicago sativa) beyond Coumestrol. J. Agric. Food Chem. 2011, 59, 131-7.